Wednesday, February 10, 2010, 1:33am EST - Canadian Markets open in 7 hours and 57 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

United Therapeutics Corp. (UTHR)

 On Feb 9: 58.63 USD  Up 1.34 (2.34%)  
MORE ON UTHR
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
United Therapeutics Corporation (NasdaqNM:UTHR) Delayed quote dataEdit
After Hours: 58.63 0.00 (0.00%) as of 4:31pm EST on 02/09/10
Last Trade: 58.63 USD
Trade Time: Feb 9
Change: Up 1.34 (2.34%)
Prev Close: 57.29
Open: 57.92
Bid: 47.54 x 700
Ask: N/A
1y Target Est: 115.88
Day's Range: 57.49 - 59.19
52wk Range: 27.35 - 99.83
Volume: 666,710
Avg Vol (3m): 693,665
Market Cap: 3.16B
P/E (ttm): 17.44
EPS (ttm): 3.36
Div & Yield: N/A (N/A%)
United Therapeutics Corp. (UTHR)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add UTHR to Portfolio   Download Data

HEADLINES
• United Therapeutics Corporation to Announce Fourth Quarter and Annual 2009 Financial Results Before Market Open on Tuesday, February 16, 2010
PRNewswire (Tue 7:00am)
• UPDATE - US FDA warns 3 drugmakers on misleading promotions
at Reuters (Wed, Feb 3)
• Lung Rx LLC, A Subsidiary Of United Therapeutics Corporation, And mondoBIOTECH holding AG Announce Today a Global Strategic Partnership Agreement for
Business Wire (Wed, Feb 3)
• 5 Stocks That Just Won't Quit
at Motley Fool (Tue, Feb 2)
• UNITED THERAPEUTICS CORP Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Fri, Jan 29)
• The Biggest Growth Stocks in Health Care
at Minyanville.com (Thu, Jan 28)
• Partnership/Buyout Rumors Make Sense for NewCardio Inc. (NWCI.OB)
BayStreet Newswire (Thu, Jan 21)
• Health Stock Short-Squeeze Opportunities
at TheStreet.com (Wed, Jan 6)
• Wall Street's 10 Favorite Stocks Right Now
at Motley Fool (Sat, Dec 26)
• United Therapeutics adds new board member
at bizjournals.com (Wed, Dec 23)
More Headlines for UTHR...
ANALYST
EPS Est (next year) (Dec-07) : N/A
EPS Est (in 2 years) (Dec-08) : N/A
Avg Rec (current)*: 1.6
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of therapeutic products for patients with chronic and life-threatening diseases.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices